Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, touched the lives of almost 500 million patients last year and while we are proud of this achievement, we have an ambition to do more!
We are delighted to inform you that this offer is part of the acquisition of Just-Evotec Biologics by Sandoz in Toulouse. This opportunity will allow you to have an impact on the lives of hundreds of millions of people through bold ideas supported by an inclusive and agile company culture.
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, touched the lives of almost 500 million patients last year and while we are proud of this achievement, we have an ambition to do more!
Just - Evotec Biologics